メニュー →
サイト内検索結果 「」
全16,951件中、3,621件~3,640件を表示しています。
[1] ・・・ [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] ・・・ [848]
[1] ・・・ [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] ・・・ [848]
7241.
[生薬成分の代謝] 代謝パラメータ『Intragastric administration』
Intragastric administration 100 mg/kg (n=6) 0.40 ± 0.05 h-1 1.75 ± 0.21 h 0.46 ± 0.19 h 314.6 ± 69.2 ng/mL 597.0 ± 55.5 ng・h/ml
612.5 ± 59.0 ng・h/ml 0-t
0-∞ 2.34 ± 0.17 h AUM 1438.5 ± 211.2
7242.
[生薬成分の代謝] 代謝パラメータ『Intragastric administration』
Intragastric administration 100 mg/kg (n=6) 0.27 ± 0.01 h-1 2.58 ± 0.11 h 0.28 ± 0.11 h 635.6 ± 151.3 ng/mL 1596.0 ± 634.7 ng・h/ml
1746.6 ± 727.2 ng・h/ml 0-t
0-∞ 3.41 ± 0.52 h AUM 6155.5 ±
7243.
[生薬成分の代謝] 代謝パラメータ『Intragastric administration』
Intragastric administration 100 mg/kg (n=6) 0.19 ± 0.05 h-1 3.85 ± 1.10 h 0.42 ± 0.20 h 24.9 ± 16.2 ng/mL 47.9 ± 17.7 ng・h/ml
57.2 ± 16.9 ng・h/ml 0-t
0-∞ 4.99 ± 1.42 h AUM 274.9 ± 71.4 ng・h
7244.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg (n=7) 25.1 ± 10.9 7.5 ± 4.6 min 197.9 ± 46.7* ng/mL 7.69 ± 3.56* μg・min/mL * The values were significantly different from 2 and 5 mg/kg (p
7245.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 20 mg/kg (n=7) NC NC NC NC Ae0-24h 0.014 ± 0.011 % of dose
GI24h 0.72 ± 0.84 % of dose
F NC Verproside 代謝パラメータ
7246.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 2g N/A N/A N/A N/A N/A 0-t N/A Estimated plasma pharmacokinetic parameters after single oral administration of 2.0 g ginger extracts 6-Gingerol 代謝パラメータ
7247.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 50 mg/kg 0.5 ± 0.3 h 124.1 ± 127.9* ng/mL 238.3 ± 64.2** ng/h/mL 0-t 4.0 ± 2.0 h F % 0.75 *P < 0.1, **P < 0.05 [ Joo et al., Journal of Pharmaceutical and Biomedical A
7248.
[生薬成分の代謝] 代謝物『Pinoresinol diglucoside』
(2S,3R,5S)-2-(hydroxymethyl)-6-(2-methoxy-4-((S)-tetrahydrofuran-2-yl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol compound with (2S,3R,5S,6R)-2-(4-((S)-1-ethoxyethyl)-2-methoxyphenoxy)-6-(hydroxymethyl)te
7249.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg 0.72 ± 0.45 h Vd 27.65 ± 17.18 L/kg 10.72 ± 3.47 L/h/kg 1.43 ± 0.44 mg/L h
1.45 ± 0.45 mg/L h 0–tn
0–∞ Notoginsenoside R1 代謝パラメータ
7250.
[生薬成分の代謝] 代謝物『Arctiin』
(3R)-4-(3,4-dimethoxybenzyl)-3-(3-methoxy-4-((3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)benzyl)dihydrofuran-2(3H)-one Arctiin 20362-31-6 C27H34O11 534.56 534.2101 535.217
7251.
[生薬成分の代謝] 代謝パラメータ『Intragastric administration』
Intragastric administration 50 mg/kg 2.08 ± 0.73 h 1.12 ± 0.31 h 162.4 ± 42.8 ng/ml 524.6 ± 132.5 ng h2/ml
532.7 ± 132.2 ng h2/ml 0-t
0-∞ Ke 0.36 ± 0.10 1/h Pharmacokinetic parameters of
7252.
[生薬成分の代謝] 代謝物『Berberine』
9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium Berberine 2086-83-1 C20H18NO4+ 336.367 336.367 336.367 Berberine 代謝物
7253.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 27 g/kg 0.28 ± 0.09 h 0.16 ± 0.04 h 102 ± 64 ng/ml 23.2 ± 5.8 ng h/ml 0-∞ Ke 2.64 ± 0.86 1/h Pharmacokinetic parameters of icariin, icariside II and osthole in rats af
7254.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg 19.24 ± 3.05 h Vd 9.65 ± 2.59 L/kg 0.46 ± 0.35 L/h/kg 30.91 ± 9.24 mg/L h
31.72 ± 9.48 mg/L h 0–tn
0–∞ Notoginsenoside R1 代謝パラメータ
7255.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg 1.67 ± 0.30 h Vd 2.91 ± 5.90 L/kg 5.22 ± 1.73 L/h/kg 2.13 ± 0.80 mg/L h
2.16 ± 0.79 mg/L h 0–tn
0–∞ R1, notoginsenoside R1; Rg1, ginsenoside Rg1; Rd,
7256.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg 4.03 ± 2.75 h Vd 15.60 ± 12.06 L/kg 1.91 ± 0.33 L/h/kg 7.71 ± 4.12 mg/L h
7.76 ± 4.11 mg/L h 0–tn
0–∞ Notoginsenoside R1 代謝パラメータ
7257.
[生薬成分の代謝] 代謝物『Swertiamarin』
(4aR,5R,6S)-4a-hydroxy-6-((2R,3S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3H)-one Swertiamarin 17388-39-5 C16H22O10 374.345
7258.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 10 mg/kg 22.16 ± 13.64 h Vd 6.20 ± 4.07 L/kg 0.12 ± 0.05 L/h/kg 105.27 ± 36.28 mg/L h
106.44 ± 36.71 mg/L h 0–tn
0–∞ Notoginsenoside R1 代謝パラメータ
7259.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 27 g/kg 4.83 ± 1.78 h 0.70 ± 0.07 h 672 ± 247 ng/ml 1810 ± 873 ng h/ml 0–∞ Ke 0.16 ± 0.06 1/h Osthol (Osthole) 代謝パラメータ
7260.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 125 mg/kg mixed solution (containing 25 mg costunolide and 100 mg dehydrocostuslacton) 4.967 h 9.000 h Cl/F 75.54 L/h/kg 0.024 L/h/kg 0.322 mg/Lh
0.331 mg/Lh 0–48
0–∞ V
[1]
・・・
[177]
[178]
[179]
[180]
[181]
[182]
[183]
[184]
[185]
[186]
[187]
・・・
[848]
全16,951件中、3,621件~3,640件を表示しています。
全16,951件中、3,621件~3,640件を表示しています。